Todays 4 Pops and Drops Stocks ( CVX, CTB, ATML, BAX )

Los Angelas, CA -- (SBWIRE) -- 09/25/2012 -- Shares of Chevron Corporati (NYSE:CVX) are trading at $117.775 and is +3.70% from its 50-day Moving Average price of $113.578 and +10.42% from its 200-day Moving Average price of $106.661. The average trading volume is 5921970 shares and its market capitalization is $231.1B. Chevron Corporation(NYSE:CVX) stock gained 0.02% to $117.78, The company last week announced a natural gas drilling success by its Australian subsidiary in the Greater Gorgon Area, located in the Carnarvon Basin, a premier hydrocarbon basin. The Satyr-2 exploration discovery well confirmed approximately 128 feet (39 meters) of net gas pay. Additionally, Howard Weil upgraded shares of Chevron from a market perform rating to an outperform rating in a research note released on Sept. 24. Howard Weil currently has $135.00 target price on the stock.

How Should Investors Trade CVX Now? Find Out Here

Cooper Tire & Rub (NYSE:CTB) are trading at $20.83 and is +1.59% from its 50-day Moving Average price of $20.5037 and +21.51% from its 200-day Moving Average price of $17.1423. The average trading volume is 999639 shares and its market capitalization is $1.299B.After an increase of 4.2%, Cooper Tire & Rubber (NYSE:CTB) has reached a current price of $20.78. The company is currently trading a volume of 780,305 shares. As a stock moves up or down, it is important to pay attention to the trading volume. This indicates the level of interest: the higher the volume, the more the interest. Investors can make use of valuation ratios to estimate whether a stock is fairly valued. The debt ratio gives users a quick measure of the amount of debt that the company has on its balance sheets compared to its assets. CTB has a high debt ratio of 75.8%. This means that the company's cash flow is significantly impacted by paying off principal and interest and that any negative change in performance or rise in interest rates could result in default. As with all financial ratios, a company's debt ratio should be compared with the industry average or similar companies.

How Should Investors Trade CTB Now? Find Out Here

Shares of Atmel Corporation (NasdaqNM:ATML) are trading at $5.915 and is -2.85% from its 50-day Moving Average price of $6.0886 and -19.10% from its 200-day Moving Average price of $7.3115. The average trading volume is 5598130 shares and its market capitalization is $2.603B. Atmel Corporation(NASDAQ:ATML) stock fell 6.70% to $5.91 after UBS AG downgraded shares of Atmel from a buy rating to a neutral rating in a report issued today. Additionally, analysts at Canaccord Genuity reiterated a buy rating on shares of Atmel in a research note to investors last week. They now have a $8.00 price target on the stock. During Monday's trading session, Atmel Corporation shares closed below the 50-day moving average of $6.06. Based on technical analysis, as long as prices remain below the moving average then investors will view this as a sign of weakness. Shares of ATML advanced $0.01 to $5.92 on heavier than usual volume. Today, the stock price ranged between $5.85 and $6.10. The stock's 52 week low is $5.44 and the high is $11.30. The development of resistance levels is critical for the entry and exit strategy. Based on the pivot points, the current support and resistance levels for ATML are $5.70 and $6.20 respectively. Investors will be monitoring the price closely as it trades within this range.

Can ATML Continue To Move Higher? See The Details

Shares of Baxter Internatio (NYSE:BAX) are trading at $61.15 and is +3.04% from its 50-day Moving Average price of $59.346 and +9.01% from its 200-day Moving Average price of $56.0944. The average trading volume is 2590520 shares and its market capitalization is $33.463B. Deutsche Bank analyst Kristen Stewart downgraded rating of Baxter International Inc. (NYSE:BAX : 61.155, 0.175) to "Hold" from "Buy" with $63 price target.Stewart decided to revisit Baxter given the outperformance of the stock this year, the publication of her Global FITT hemophilia report, and the upcoming analyst day.The analyst believes the market is already viewing the analyst meeting as a positive catalyst and as she moves beyond it, recombinant competition concerns are likely to become more of an overhang as competitors release data in the coming months. Alzheimer's is a wildcard; the analyst doesn't feel comfortable using that to justify being more positive. Though she sees the potential for some upside to the current price, particularly around the analyst meeting, it is no longer enough to support a "Buy" rating and hence she downgraded the rating.

Can BAX Continue To Move Higher? See The Details

Disclaimer:
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..

Contact:
hotpennystocknews.com
info@hotpennystocknews.com